Relapsed Chronic Lymphocytic Leukemia (慢性リンパ性白血病):グローバル臨床試験動向(2014年上半期)...市場調査レポートについてご紹介

【英文タイトル】Relapsed Chronic Lymphocytic Leukemia (CLL) Global Clinical Trials Review, H1, 2014

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents
Table of Contents2
List of Tables 4
List of Figures 6
Introduction 7
Relapsed Chronic Lymphocytic Leukemia (CLL) 7
Report Guidance 7
Clinical Trials by Region 8
Clinical Trials and Average Enrollment by Country 9
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by G7 Countries: Proportion of Relapsed Chronic Lymphocytic Leukemia (CLL) to Oncology Clinical Trials 16
Clinical Trials by Phase in G7 Countries 17
Clinical Trials in G7 Countries by Trial Status 18
Clinical Trials by E7 Countries: Proportion of Relapsed Chronic Lymphocytic Leukemia (CLL) to Oncology Clinical Trials 19
Clinical Trials by Phase in E7 Countries 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Relapsed Chronic Lymphocytic Leukemia (CLL) 25
Subjects Recruited Over a Period of Time 26
Clinical Trials by Sponsor Type 27
Prominent Sponsors 28
Top Companies Participating in Relapsed Chronic Lymphocytic Leukemia (CLL) Therapeutics Clinical Trials 29
Prominent Drugs 30
Latest Clinical Trials News on Relapsed Chronic Lymphocytic Leukemia (CLL) 31
Dec 09, 2013: Emergent BioSolutions Presents Positive Interim Phase 2 Data Evaluating Otlertuzumab in Combination with Bendamustine in People with Relapsed Chronic Lymphocytic Leukemia 31
Dec 09, 2013: Interim Phase IIa Results for Spiegelmer Olaptesed Pegol in CLL and MM Studies 31
Nov 25, 2013: TG Therapeutics Initiates First Combination Clinical Trial of TG-1101 and TGR-1202 in Patients With Relapsed and/or Refractory CLL and NHL 33
Oct 07, 2013: MorphoSys and Xencor Provide Update on Phase 1/2a Trial in CLL/SLL for MOR208 33
Clinical Trial Profiles 35
Clinical Trial Overview of Top Companies 35
F. Hoffmann-La Roche Ltd. 35
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 35
Pharmacyclics, Inc. 37
Clinical Trial Overview of Pharmacyclics, Inc. 37
GlaxoSmithKline plc 38
Clinical Trial Overview of GlaxoSmithKline plc 38
Celgene Corporation 39
Clinical Trial Overview of Celgene Corporation 39
AbbVie Inc. 40
Clinical Trial Overview of AbbVie Inc. 40
Janssen Global Services, LLC 41
Clinical Trial Overview of Janssen Global Services, LLC 41
Sanofi 42
Clinical Trial Overview of Sanofi 42
Gilead Sciences, Inc. 43
Clinical Trial Overview of Gilead Sciences, Inc. 43
Bristol-Myers Squibb Company 44
Clinical Trial Overview of Bristol-Myers Squibb Company 44
AstraZeneca PLC 45
Clinical Trial Overview of AstraZeneca PLC 45
Clinical Trial Overview of Top Institutes / Government 46
National Cancer Institute 46
Clinical Trial Overview of National Cancer Institute 46
The University of Texas M. D. Anderson Cancer Center 47
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center 47
Ohio State University Comprehensive Cancer Center 48
Clinical Trial Overview of Ohio State University Comprehensive Cancer Center 48
Massachusetts General Hospital 49
Clinical Trial Overview of Massachusetts General Hospital 49
Eastern Cooperative Oncology Group 50
Clinical Trial Overview of Eastern Cooperative Oncology Group 50
Fred Hutchinson Cancer Research Center 51
Clinical Trial Overview of Fred Hutchinson Cancer Research Center 51
Roswell Park Cancer Institute 52
Clinical Trial Overview of Roswell Park Cancer Institute 52
University of Kentucky 53
Clinical Trial Overview of University of Kentucky 53
Beth Israel Deaconess Medical Center 54
Clinical Trial Overview of Beth Israel Deaconess Medical Center 54
Duke University 55
Clinical Trial Overview of Duke University 55
Five Key Clinical Profiles 56
Appendix 182
Abbreviations 182
Definitions 182
Research Methodology 183
Secondary Research 183
About GlobalData 184
Contact Us 184
Disclaimer 184
Source 185


【レポート販売概要】

■ タイトル:Relapsed Chronic Lymphocytic Leukemia (慢性リンパ性白血病):グローバル臨床試験動向(2014年上半期)
■ 英文:Relapsed Chronic Lymphocytic Leukemia (CLL) Global Clinical Trials Review, H1, 2014
■ 発行日:2014年5月26日
■ 調査会社:GlobalData
■ 商品コード:GDHC2159CTIDB
■ 調査対象地域:グローバル
  • シャワーヘッド及びパネルの世界市場2016-2020
    Technavio market research analyst estimates the global showerhead and panel market to gain immense popularity during the forecast period. Rapid urbanization and growing awareness pertaining to energy and water conservation are the two major factors that bolster growth in this market and results in its modest CAGR of more than 4% by 2020. In this market research report, analysts estimate eminent fa …
  • 皮膚科用医療機器の世界市場:皮膚科用診断装置、皮膚科用治療装置
    In this report, the dermatology devices market is segmented on the basis of applications, products, and geographies. The application segments included in this report are diagnostic applications and treatment applications. The diagnostic applications are further segmented into skin cancer diagnosis and other diagnostic applications; whereas, the treatment applications include hair removal, skin rej …
  • 芳香物質の世界市場2017-2021:テルペン、ベンゼノイド、じゃこう化学品
    About Aroma ChemicalsAroma chemicals, also called odorants or fragrances, are natural or synthetic compounds that are characterized by their pleasant smell. These compounds are usually obtained from essential oils and the aromatic compounds. They have a molecular weight less than 300 Da and are extremely volatile and tend to vaporize. Aroma chemicals are used in the products to provide a specific …
  • 世界の企業用モバイルセキュリティソフトウェア市場
    About Mobile Enterprise Security Software Mobile enterprise security software secures the mobile workforce. It delivers a simplified, streamlined way to enable productivity with confidence in a world where users, and their devices, go everywhere and anywhere. Mobile productivity presents risks to mobile devices and data, including malware, loss, theft, and unauthorized access. Businesses work hard …
  • 世界の電子書籍(e-Book)市場(2014-2018)
    About E-books e-books are books available in a digital format, which allows readers to access content anywhere and anytime using their handheld devices. The Global e-Book market is the fastest growing segment in Global Book Publishing industry. It accounts for approximately 11.9 percent of total Book Publishing market in 2013. The segment contribution is expected to reach 26.3 percent by 2018. Tec …
  • データベース暗号化の世界市場:透過的暗号化、ファイルシステム暗号化、アプリケーションレベル暗号化、列レベル暗号化、ハッシュ、鍵管理
    The database encryption market is expected to grow from USD 261.8 Million in 2015 to USD 968.3 Million by 2020, at a Compound Annual Growth Rate (CAGR) of 29.9%. In 1961, a computer based login and password was developed to allow more users to work on a single machine. This increased the risk of data leakage due to which, in 1979, the Data Encryption Standard was launched. In 1996, another standar …
  • 医療産業におけるLBS(位置情報サービス)の世界市場2016-2020
    About the Location-Based Services (LBS) in the healthcare industry The use of LBS in the healthcare industry can improve the operational efficiency of small and large hospitals worldwide. The growth of the market is driven by several factors such as the increased deployment of RTLS tags inside hospitals and the improvement in Wi-Fi and wireless land area network (WLAN) infrastructure of hospitals. …
  • 中国のカーテンウォール市場2016-2020
    About Curtain Wall Curtain walls are lightweight, non-structural exterior cladding systems, which are attached to the external walls of buildings. Curtain walls comprise a lightweight aluminum frame containing glass, metal panels, and thin stone. The weight of the curtain walls is borne by the building. Technavio’s analysts forecast the curtain wall market in China to grow at a CAGR of 18.98% duri …
  • デュシェンヌ型筋ジストロフィー治療薬の世界市場機会分析
    OpportunityAnalyzer: Duchenne Muscular Dystrophy - Opportunity and Market Analysis to 2019 Summary Duchenne muscular dystrophy (DMD) is a rare genetic disorder affecting approximately 1 in 3,500 newborn boys and is characterized by progressive muscle degeneration, loss of ambulation, and death by the late 20s. There are no marketed pharmacological therapies that are indicated for DMD. The current …
  • パルプの世界市場:木材パルプ、化学パルプ、機械パルプ、非木材パルプ
    About the Pulp Market Pulp is a type of fibrous material that is largely composed of water, cellulose fibers, lignin, and hemicelluloses. Cellulose fibers are essential for the production of paper, while lignin is a type of polymer that binds these fibers together. Hemicellulose, like cellulose, is a carbohydrate-based polymer that binds closely to cellulose fibers and along with cellulose fibers, …
  • ヘアマスクの世界市場:性質別(ナチュラル、オーガニック、および合成)、エンドユーザー別(家庭用、商業用)、流通経路別(オンライン、オフライン)
    The global hair mask market was valued at $597.7 million in 2018 and is projected to reach $886.4 million by 2026, growing at a CAGR of 5.1% from 2019 to 2026. The global hair mask market is segmented on the basis of nature, application, distribution channel, and region. Based on product type, the market is classified into natural, organic and synthetic. By application, the market is segmented int …
  • Namenda XR (Alzheimer’s Disease):市場予測と分析(~2022)
    Namenda XR (Alzheimer’s Disease) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Namenda XR (Alzheimer’s Disease) - Forecast and Market Analysis to 2022”. There are no long-term effective therapies for Alzheimer’s Disease (AD), so this remains at the top of the list for unmet needs. While physicians agree that symptomatic therapie …
  • 実験室備品の世界市場:ラベルプリンター、ピペットチップ、マイクロプレート、試薬リザーバー、バルブ、チューブ、洗浄ステーション
    The dearth of qualified laboratory professionals (over 17% of laboratory professionals are set to retire in the next five years) and rising aging population have increased the demand for laboratory automation. The application of advanced technology in testing laboratories has gained importance as it ensures timely progress and efficiency with minimal errors. This has led to the adoption of lab aut …
  • グローバルにおけるスイッチギヤ市場動向
    A switchgear is a combination of devices designed to control, regulate, meter and protect electric generation, transmission and distribution equipment, and electric motor control systems. The global market for switchgears is anticipated to do well in the coming times as demand is likely to be driven by medium and high voltage types of switchgears. Revenues in the switchgears market are closely tie …
  • 酸化防止剤BHTの世界市場
    Antioxidant BHT (CAS 128-37-0) Market Research Report 2014 presents comprehensive data on antioxidant BHT markets globally and regionally (Europe, Asia, North America etc.) The report includes antioxidant BHT description, covers its application areas and related patterns. It overviews antioxidant BHT market, names antioxidant BHT producers and indicates its suppliers. Besides, the report provides …
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。